Grown Rogue International (GRUSF) Accounts Payables (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Accounts Payables came in at $2.7 million in Q1 2026, up 55.31% year-on-year from $1.8 million in Q1 2025, and up 116.36% quarter-over-quarter from $1.3 million in Q4 2025.
Grown Rogue International (GRUSF) Accounts Payables (2009 - 2026) Analysis & Trends
Grown Rogue International's Accounts Payables history runs 18 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- On a quarterly basis, Accounts Payables rose 55.31% year-over-year to $2.7 million in Q1 2026; TTM through Mar 2026 was $2.7 million, a 55.31% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 53.08% from the prior year.
- Accounts Payables rose to $2.7 million in Q1 2026 per GRUSF's latest filing, from $1.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $1981.8 billion in Q3 2025 and bottomed at $114351.8 in Q4 2023.
- The 5-year median for Accounts Payables is $1.5 million (2025), against an average of $141.6 billion.
- Across the five-year window, Accounts Payables slumped 69.78% in 2023 and surged 127568895.65% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $464043.3 in 2022, then slumped by 75.36% to $114351.8 in 2023, then climbed by 8.17% to $123695.2 in 2024, then jumped by 920.67% to $1.3 million in 2025, then jumped by 116.36% to $2.7 million in 2026.
- Per Business Quant, the three latest GRUSF Accounts Payables figures stand at $2.7 million (Q1 2026), $1.3 million (Q4 2025), and $1981.8 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 2.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1,981.79 Bn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 1.76 Mn |
| Dec 31, 2024 | 123,695.15 |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 114,351.76 |
| Oct 31, 2023 | 140,248.48 |
| Apr 30, 2023 | 1.61 Mn |
| Jan 31, 2023 | 1.66 Mn |
| Oct 31, 2022 | 464,043.33 |
| Oct 31, 2021 | -234,531.65 |
| Apr 30, 2021 | 1.10 Mn |
| Jan 31, 2021 | 1.28 Mn |
| Oct 31, 2020 | 45,000.00 |
| Jul 31, 2020 | 1.02 Mn |
| Apr 30, 2020 | 1.33 Mn |